Figure 1.
Association between overall survival and RECIST BSLD. (A) BSLD dichotomised at median value. (B) BSLD categorised by quartile. (C) Dichotomised BSLD and treatment group. Abbreviations: BPC, bevacizumab-paclitaxel-carboplatin; BSLD, baseline sum longest diameter; PC, paclitaxel-carboplatin; RECIST, response evaluation criteria in solid tumours.